top of page

STAIR XIII

Stroke Treatment Academic Industry Roundtable

STAIR XII Badge 1.0.jpg

March 27-28, 2025

STAIR XIII

"INTEGRATING CYTOPROTECTION AND REPERFUSION"

 New Perspectives on Expanding and Combining Research and Development of Acute Stroke Treatment Drugs and Devices

STAIR XII Badge 1.0.jpg

Program

STAIR XII Badge 1.0.jpg

Faculty

STAIR XII Badge 1.0.jpg

Industry Sponsors

STAIR XII Badge 1.0.jpg

FDA Support Statement

STAIR XII Badge 1.0.jpg

Conference Videos
Available only to STAIR Participants

STAIR XII Badge 1.0.jpg

Publications

Workshop 1 - Optimizing Reperfusion Trials

Workshop 2 - Priorities for Cytoprotection Trials

Workshop 3 - Artificial Intelligence and Novel Trial Designs

Publications

The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into existing, new and prospective drugs and devices for the treatment of stroke. The information is not intended to be a substitute for rigorous independent testing and development of individual compounds and devices by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgment or informed treatment decisions.

STAIR® is a Registered Trademark of The Stroke Group.   

© 2025 The Stroke Group

bottom of page